Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
Liability | Insurance
Exhibit E: UBC Terms and Conditions
a) During the Agreement Term (and for a period which is the longer of either three (3) years after the end of the Agreement Term, or three (3) years after the last Licensed Product is sold) each Payor and its Related Parties will procure and maintain insurance (including public liability and commercial general liability insurance), as would be acquired by a reasonable and prudent businessperson carrying on a similar line of business.
b) Notwithstanding Subsection (a) above, one month before the start of any Licensed Product testing involving human subjects (“Human Clinical Trials”) each Payor will give notice to UBC of the terms and amount of the product liability, clinical trials, public liability, and commercial general liability insurance and such other types of insurance which it and/or its Related Parties have placed. This insurance will (i) include the UBC Indemnitees and AlCana Indemnitees as additional insureds; (ii) provide coverage regarding all activities under this Agreement and the Supplemental Agreement; (iii) include a waiver of subrogation against the UBC Indemnitees and AlCana Indemnitees, and a severability of interest and cross-liability clauses; and (iv) provide that the policy cannot be cancelled or materially altered except on at least [**] days’ prior notice to UBC. Each Payor will provide to UBC certificates of insurance evidencing the coverage [**] days before the start of any Human Clinical Trials. Without limiting the generality of the forgoing, no Payor or any of it Related Parties will: (x) start any Human Clinical Trials, or (y) sell any Licensed Product; at any time unless an insurance certificate is provided to UBC, and the insurance outlined above is in effect.
We are seeking additional content for the MAPGuideⓇ in the form of either full agreements or individual provisions, which may be attributed or anonymized. Please use the form below to submit an agreement or provision.
The MAPGuideⓇ is supported by the Wellcome Trust (grant numbers 219632/Z/19/Z, 221648/Z/20/Z and 225262/Z/22/Z).
If you are interested in providing funding or an in-kind contribution to support GHIAA’s work, please contact us using the form below.
Special thanks to our supporters at Duke Law SchoolCommunity Enterprise Clinic
Global Health Innovation Alliance Accelerator is a 501(c)(3) non-profit recognized by the IRS.
MAPGuideⓇ by the Global Healthcare Innovation Alliance Accelerator is licensed under CC-BY-NC-ND 4.0. To request permission for commercial or derivative use, contact firstname.lastname@example.org.
This website and the MAPGuideⓇ are provided for general informational purposes only. By using this website and any element of the MAPGuideⓇ, you agree that the information provided does not constitute legal, financial or any other form of professional advice. No relationship is created with you, nor any duty of care assumed to you, when you use this website or the MAPGuideⓇ. Neither this website nor the MAPGuide are a substitute for obtaining any legal, financial or any other form of professional advice from a suitably qualified and licensed advisor. The information provided on this website and the MAPGuideⓇ may be changed without notice and is not guaranteed to be complete, accurate, correct or up-to-date. For further information please see our Terms of Service.